Compile Data Set for Download or QSAR
Report error Found 891 of affinity data for UniProtKB/TrEMBL: Q13258
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM62356(US9422273, 12b)
Affinity DataEC50:  17nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM240744(US9422273, 12a)
Affinity DataEC50: <1nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM240745(US9422273, 12c)
Affinity DataEC50: <1nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM240746(US9422273, 12d)
Affinity DataEC50:  3nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM240747(US9422273, 12e)
Affinity DataEC50:  18nMpH: 7.4 T: 2°CAssay Description:Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throug...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50205275([(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfony...)
Affinity DataKd:  0.0300nMAssay Description:Binding affinity to human DP receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103398(CHEMBL3398206)
Affinity DataEC50:  21nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103399(CHEMBL3398208)
Affinity DataEC50:  17nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103400(CHEMBL3398209)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103401(CHEMBL3398210)
Affinity DataEC50:  44nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103402(CHEMBL3398211)
Affinity DataEC50:  61nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103403(CHEMBL3398212)
Affinity DataEC50:  6nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103404(CHEMBL3398228)
Affinity DataEC50:  400nMAssay Description:Agonist activity at human recombinant DP1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103396(CHEMBL3398236)
Affinity DataEC50:  140nMAssay Description:Agonist activity at human recombinant DP1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103405(CHEMBL3398215)
Affinity DataEC50:  1.70nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103406(CHEMBL3398218)
Affinity DataEC50:  31nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103407(CHEMBL3398219)
Affinity DataEC50:  3nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103408(CHEMBL3398220)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103409(CHEMBL3398221)
Affinity DataEC50:  24nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103410(CHEMBL3398222)
Affinity DataEC50:  180nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103411(CHEMBL3398223)
Affinity DataEC50:  48nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103412(CHEMBL3398224)
Affinity DataEC50:  88nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103413(CHEMBL3398227)
Affinity DataEC50:  31nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103404(CHEMBL3398228)
Affinity DataEC50:  36nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103394(CHEMBL3398229)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103395(CHEMBL3398235)
Affinity DataEC50:  42nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103396(CHEMBL3398236)
Affinity DataEC50:  48nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50103397(CHEMBL3398237)
Affinity DataEC50:  21nMAssay Description:Agonist activity at human recombinant DP1 receptor expressed in melanophores assessed as induction of pigment redistribution incubated for 90 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2016
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM23954(CHEMBL494 | ILOPROST | 5-[(2E,3aS,4R,5R,6aS)-5-hyd...)
Affinity DataEC50:  147nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235387(CHEMBL239226)
Affinity DataEC50:  154nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235388(CHEMBL3943791)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235389(CHEMBL3983767)
Affinity DataEC50:  808nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235390(CHEMBL3952439)
Affinity DataEC50:  860nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235391(CHEMBL3914174)
Affinity DataEC50:  1.14E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235379(CHEMBL3932106 | US10668033, Compound 55)
Affinity DataEC50:  1.03E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235378(CHEMBL3981509)
Affinity DataEC50:  5.00E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235377(CHEMBL3890685)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235376(CHEMBL3926078)
Affinity DataEC50:  2.05E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235375(CHEMBL3975122)
Affinity DataEC50:  620nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235374(CHEMBL3935924)
Affinity DataEC50:  320nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235373(CHEMBL3928729)
Affinity DataEC50:  1.72E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235372(CHEMBL3966307)
Affinity DataEC50:  5.07E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235371(CHEMBL3922000)
Affinity DataEC50:  3.87E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235370(CHEMBL3933704)
Affinity DataEC50:  2.76E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235368(CHEMBL3893346)
Affinity DataEC50:  240nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235386(CHEMBL3919269)
Affinity DataEC50:  980nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235385(APD-811 | Ralinepag)
Affinity DataEC50:  850nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235384(CHEMBL3900038)
Affinity DataEC50:  1.71E+3nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235367(CHEMBL3952237)
Affinity DataEC50:  355nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Allergan

US Patent
LigandPNGBDBM50235383(ACT-293987 | NS-304 | Selexipag | Uptravi)
Affinity DataEC50:  100nMAssay Description:Agonist activity at recombinant human DP1 receptor expressed in CHO-K1 cells assessed as increase in intracellular cAMP level after 1 hr incubation b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2019
Entry Details Article
PubMed
Displayed 1 to 50 (of 891 total ) | Next | Last >>
Jump to: